WHITEHEAD v. SECRETARY OF HEALTH AND HUMAN SERVICES

United States Court of Federal Claims·Decided March 25, 2024·No. 18-1538·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-1538V (Not to be Published)

************************* * DURENDA WHITEHEAD and * KEYNARD SHAWTELL JOHNSON, SR., * on behalf of KSJ, JR, * Chief Special Master Corcoran * Petitioners, * Filed: February 27, 2024 * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * *************************

Julius Vincent Cook, Cook & Tolley, LLP, Athens, GA, for Petitioner.

Zoe Wade, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION AWARDING DAMAGES 1

On October 4, 2018, Durenda Whitehead and Keynard Shawtell Johnson filed a petition on behalf of their minor son, K.S.J., Jr. (“K.J.”) seeking compensation under the National Vaccine Injury Compensation Program. 2 (ECF No. 1). Petitioners alleged that K.J. suffered vaccine- induced seizures and encephalopathy as a result of receiving the measles, mumps, rubella, and varicella vaccine on January 17, 2017. Petition at 1. Alternatively, they alleged that receipt of

1 Because this decision contains a reasoned explanation for my actions in this case, I will post it on the United States Court of Federal Claims website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will be available to the public. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). several vaccines ((including the influenza, hepatitis A, diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio vaccine, haemophilus influenza type B, and pneumococcal conjugate (“PCV12”) vaccines) on January 17, 2017 caused K.J. to suffer the “activation of his SLC19A3 gene variant” leading him to experience an “SLC19A3-related encephalopathy.” Petitioner’s Prehearing Brief, filed Nov. 19, 2020 (ECF No. 32).

I held an entitlement hearing in the matter, and found in favor of Petitioners. Ruling on Entitlement. (ECF No. 42). On January 5, 2024, Respondent filed a proffer proposing an award of compensation. (ECF No. 59). I have reviewed the file, and based upon that review I conclude that the Respondent’s proffer (as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein.

The proffer awards:

• A lump sum payment of $1,616,572.94 representing compensation for pain and suffering ($250,000.00), life care expenses for the first year after judgment ($251,934.06) and future lost earnings ($1,114,638.88), in the form of a check payable to Petitioners as guardians/conservators of K.J.’s estate (see terms in the attached Proffer); and

• An amount sufficient to purchase an annuity contract to provide payments for the items in the life care plan, as described in the attached proffer.

Proffer at II. These amounts represent compensation for all elements of compensation under 42 U.S.C. § 300aa-15(a) to which Petitioners are entitled.

The Proffer also specifies that:

“No payments shall be made until petitioners provide respondent with documentation establishing that they have been appointed as the guardian(s)/conservator(s) of K.J.’s estate. If petitioners are not authorized by a court of competent jurisdiction to serve as guardian(s)/conservator(s) of the estate of K.J., any such payment shall be made to the party or parties appointed by a court of competent jurisdiction to serve as guardian(s)/conservator(s) of the estate of K.J. upon submission of written documentation of such appointment to the Secretary.”

I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioners, in accordance with the forementioned terms (including the guardianship

2 requirements). In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court is directed to enter judgment herewith. 3

IT IS SO ORDERED.

/s/ Brian H. Corcoran Brian H. Corcoran Chief Special Master

3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) a notice renouncing their right to seek review.

3 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS __________________________________________ ) DURENDA WHITEHEAD and ) KEYNARD SHAWTELL JOHNSON, SR., ) on behalf of KSJ, JR. ) ) Petitioners, ) ) v. ) No. 18-1537V ) Chief Special Master Corcoran SECRETARY OF THE DEPARTMENT OF ) ECF HEALTH AND HUMAN SERVICES, ) ) Respondent. ) __________________________________________)

RESPONDENT’S PROFFER ON AWARD OF COMPENSATION

On October 4, 2018, Durenda Whitehead and Keynard Shawtell Johnson, Sr.,

(“petitioners”), on behalf of her minor son, K.S.J., Jr. (hereinafter referred to as “K.J.”), filed a

petition for compensation under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C.

§§ 300aa-1 to -34 (“Vaccine Act” or “Act”), alleging that as a result of receiving the measles,

mumps, rubella and varicella (“MMRV”) vaccine on January 17, 2017, K.J. suffered vaccine-

induced seizures and encephalopathy. Petition at 1 (ECF No. 1). In the alternative, Petitioners

alleged that K.J.’s receipt of several vaccines on January 17, 2017 (including the MMRV,

influenza, hepatitis A, diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio

vaccine, haemophilus influenza type B, and pneumococcal conjugate (“PCV12”) vaccines,

caused him to suffer “the activation of his SLC19A3 gene variant,” leading him to experience an

“SLC19A3-related encephalopathy.” Petitioners’ Prehearing Brief, filed Nov. 19, 2020 (ECF

No. 32). On September 29, 2021, Chief Special Master Corcoran issued a Ruling on Entitlement in favor of petitioners. ECF No. 42. Respondent now proffers the following regarding the amount of

compensation to be awarded. 1

I. Items of Compensation

A. Life Care Items

Respondent engaged life care planner M. Virginia Walton, M.S.N., RN, FNP, CLCP, and

petitioners engaged Audrey Cowart, M.Ed., CRC, LPC, CLCP, to provide an estimation of K.J.’s

future vaccine-injury related needs. For the purposes of this proffer, the term “vaccine related”

is as described in the Special Master’s September 29, 2021, Ruling on Entitlement. All items of

compensation identified in the life care plan are supported by the evidence and are illustrated by

the chart entitled Appendix A: Items of Compensation for K.J., attached hereto as Tab A. 2

Petitioners agree.

B. Lost Future Earnings

Free access — add to your briefcase to read the full text and ask questions with AI

WHITEHEAD v. SECRETARY OF HEALTH AND HUMAN SERVICES, (uscfc 2024).

WHITEHEAD v. SECRETARY OF HEALTH AND HUMAN SERVICES (WHITEHEAD v. SECRETARY OF HEALTH AND HUMAN SERVICES) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 300aa-1
42 U.S.C. § 300aa-1
§ 300aa-10
42 U.S.C. § 300aa-10
§ 300aa-12
42 U.S.C. § 300aa-12(d)(4)(B)
§ 300aa-15
42 U.S.C. § 300aa-15(a)
Purposes
44 U.S.C. § 3501
§ 300a
42 U.S.C. § 300a